U.S. Biotech Stock News

NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Assessing Trinity Capital (TRIN) Valuation After Q4 Guidance And Low Non Accrual Update

Trinity Capital (TRIN) is back in focus after issuing preliminary fourth quarter 2025 guidance, indicating net investment income of $0.51 to $0.53 per share and reporting that approximately 0.7% of its debt investments are on non-accrual. See our latest analysis for Trinity Capital. The preliminary guidance and low 0.7% non accrual level come as Trinity Capital’s share price sits at US$16.19, with a 30 day share price return of 5.47% and a 90 day gain of 10.89%. The 1 year total shareholder...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor (NUE) Valuation Check After Strong Q4 Results And Earnings Growth Outlook

Nucor (NUE) is back in focus after reporting fourth quarter 2025 results showing higher sales and net income than a year earlier, along with guidance calling for first quarter earnings growth across all segments. See our latest analysis for Nucor. The earnings update comes after a strong run in Nucor’s share price, with a 30 day share price return of 17.01% and a 90 day share price return of 33.63%. The 1 year total shareholder return of 50.46% points to momentum that has been building rather...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Assessing Credo Technology Group Holding (CRDO) Valuation After AI Growth Momentum And Blue Heron Launch

Blue Heron launch puts Credo’s AI connectivity story in focus Credo Technology Group Holding (CRDO) has introduced its Blue Heron 224G AI scale-up retimer, a multiprotocol chip built on a 3nm process to support demanding connectivity requirements inside AI data centers. The product is designed to recover 40+dB 224G links across extended cable and backplane distances using UALink, ESUN and Ethernet, giving data center operators more flexibility in how they place GPUs and switch chips. See our...
NYSE:VRTS
NYSE:VRTSCapital Markets

Virtus Investment Partners (VRTS) Margin Expansion Challenges Bearish Profitability Narratives

Virtus Investment Partners (VRTS) has wrapped up FY 2025 with Q4 revenue of US$208.0 million and basic EPS of US$5.25, alongside trailing 12 month revenue of US$852.9 million and EPS of US$20.27, setting a clear marker for its recent performance. Over the past year, the company has seen revenue shift from US$906.9 million to US$852.9 million on a trailing basis. At the same time, trailing 12 month net income moved from US$121.7 million to US$138.4 million, reflecting the mix of pressure and...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

eToro Gemini Offboarding Deal Puts Execution And Perception Under Spotlight

eToro Group is working with Gemini on the offboarding process for Gemini customers in the UK, EU, and Australia. The collaboration follows Gemini's decision to exit these regions, affecting users who hold trading and crypto accounts there. The move positions eToro as a potential destination for some of these customers during the transition. For investors watching NasdaqGS:ETOR, this development sits against a recent share price of $27.01. The stock has seen a 7 day return of an 8.1%...
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

Is Snap (SNAP) Using Buybacks and Subscriptions to Redefine Its Profit Playbook?

In early February 2026, Snap Inc. reported fourth-quarter 2025 results showing revenue of US$1,716.46 million and net income of US$45.21 million, alongside a Board-approved US$500 million Class A share repurchase program funded from existing cash. The company highlighted rapid growth in its Snapchat+ subscription base, progress toward higher margins, and plans to launch AR Specs through a dedicated hardware subsidiary while continuing to invest in AI-driven advertising. We’ll now examine how...
NYSE:MOH
NYSE:MOHHealthcare

Molina Healthcare Loss And Covenant Shift Put Contract Risks In Focus

Molina Healthcare (NYSE:MOH) reported a large quarterly loss, citing sustained margin pressures and retroactive premium adjustments tied to its California Medicaid business. The company recorded a US$93 million impairment to intangible assets, pointing to financial strain in parts of its portfolio. Molina issued weak guidance for 2026 and significantly revised its credit agreement, including a temporary relaxation of its interest coverage covenant. Molina Healthcare focuses on government...
NYSE:JPM
NYSE:JPMBanks

Why JPMorgan (JPM) Is Up 5.4% After Boosting Banker Bonuses Over 20% And What's Next

In early February 2026, reports indicated that JPMorgan Chase significantly increased bonus pools for bankers and traders after a strong year in dealmaking and market activity, with some top performers receiving raises of over 20%. The decision highlights how robust investment banking and trading revenues are feeding directly into compensation, raising questions about future cost discipline and profitability trade-offs as the firm leans more on performance-based pay. With JPMorgan Chase...
NYSE:VAL
NYSE:VALEnergy Services

Is It Too Late To Consider Valaris (VAL) After Its Recent Share Price Run

If you are wondering whether Valaris is still good value after its recent run, the starting point is understanding how the current share price lines up against a few different valuation yardsticks. The stock last closed at US$62.41, with returns of 8.1% over the past week, 21.5% over the past month, 19.7% year to date and 36.1% over the past year, while the 3 year return sits at a 20.7% decline. Recent trading activity has kept Valaris on the radar of investors who follow offshore drilling...
NYSE:NOW
NYSE:NOWSoftware

ServiceNow (NOW) Is Down 13.9% After AI-Fueled Beat, Raised Outlook And Bigger Buyback Authorization

In late January 2026, ServiceNow reported fourth-quarter and full-year 2025 results showing higher revenue and earnings, raised its 2026 subscription revenue outlook, expanded its equity buyback authorization to US$9.50 billion, and announced deeper AI collaborations and large enterprise wins with partners including Anthropic, Panasonic Avionics, and Fiserv. An important twist is that ServiceNow highlighted rapid AI adoption across its platform, such as Now Assist and Claude-powered Build...
NasdaqGS:NTRS
NasdaqGS:NTRSCapital Markets

Is Strong Q4 Profitability Guidance Altering The Investment Case For Northern Trust (NTRS)?

Northern Trust recently reported strong fourth-quarter 2025 results, with higher pre-tax pre-provision income, lower provisions, and revenue above market forecasts, and raised its medium-term pre-tax margin and return-on-equity targets to reflect greater confidence in its profitability profile. At the same time, the firm highlighted momentum in fee-based businesses and effective expense management, reinforcing how its operating model can support improved efficiency and returns over...
NYSE:NGL
NYSE:NGLOil and Gas

Is Nuclear-Powered Water Treatment Transforming the Investment Case For NGL Energy Partners (NGL)?

NGL Energy Partners LP recently reported its third-quarter and nine-month results to December 31, 2025, showing higher net income despite lower revenue and highlighting record performance in its Water Solutions segment. A separate announcement from Natura Resources LLC revealed a collaboration with NGL to pair molten-salt nuclear reactor technology with produced water treatment and desalination, underscoring NGL’s push to turn produced water into a long-term infrastructure business. We’ll...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Southern Copper (SCCO) Is Up 5.1% After Strong Q4 Results and Ramped-Up Dividends - What's Changed

Southern Copper Corporation recently reported fourth-quarter 2025 sales of US$3,869.8 million and net income of US$1,307.9 million, alongside a higher full-year profit, and announced a quarterly cash dividend of US$1 per share plus a stock dividend of 0.0085 shares per share. The combination of stronger year-over-year earnings and an enhanced mix of cash and stock dividends signals management’s confidence in returning more capital to shareholders. With this backdrop of robust earnings growth...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Assessing Costco Wholesale (COST) Valuation After Strong January Sales And Ongoing Membership Momentum

Costco Wholesale (COST) just reported January net sales of US$21.33b, up 9.3% year on year, alongside 7.1% comparable sales growth and strong digital gains, giving investors fresh insight into the membership driven warehouse model. See our latest analysis for Costco Wholesale. The strong January sales update has arrived alongside a sharp rebound in Costco Wholesale’s share price, with a 30 day share price return of 13.44% and a year to date share price return of 17.16% helping reverse last...
NYSE:WELL
NYSE:WELLHealth Care REITs

Baron Fund Move Puts Welltower Senior Housing Story In Spotlight

Baron Health Care Fund has initiated a new position in Welltower (NYSE:WELL). The fund cites strong secular demand trends in senior housing as a key factor. Baron also highlights confidence in Welltower's management and its all in compensation program. For you as an investor, this move puts fresh attention on Welltower, a major real estate investment trust focused on senior housing and health care properties. The fund's interest aligns with long term demand drivers such as aging populations...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock Bitcoin ETF Volatility Raises New Questions On Systemic Risk

BlackRock’s spot Bitcoin ETF, IBIT, saw record trading volumes and options activity during a sharp market sell off. Reports indicate leveraged positions tied to IBIT may have contributed to hedge fund failures and faster market downside. The episode has raised questions about the ETF’s systemic importance and its role in amplifying short term volatility. For an asset manager of BlackRock’s scale, NYSE:BLK, the episode is more than a single product story. IBIT sits at the intersection of...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Move

Why Madrigal Pharmaceuticals Is On Investors’ Radar Madrigal Pharmaceuticals (MDGL) has drawn attention after a recent move in its share price, with the stock up 3.1% over the past day but showing weaker returns over the past month. See our latest analysis for Madrigal Pharmaceuticals. The 3.1% one-day share price gain comes after weaker recent momentum, with a 30-day share price return of a 14.9% decline and a year-to-date share price return of a 19.6% decline. However, the 1-year total...
NYSE:CPK
NYSE:CPKGas Utilities

Is Chesapeake Utilities (CPK) Pricing In Too Much Stability After Its Recent Share Rise?

If you are wondering whether Chesapeake Utilities at around US$129.87 is offering fair value or if you might be paying up for reliability, this article is designed to help you assess that question clearly. The stock has returned 0.9% over the last 7 days, 7.4% over 30 days, 4.5% year to date, 7.4% over 1 year and 40.2% over 5 years, which may have some investors rethinking both its growth potential and its risk profile. Recent coverage of Chesapeake Utilities has focused on its role as a...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Assessing First Merchants (FRME) Valuation After Annual Earnings Highlight Net Income Growth And Higher Net Charge Offs

Annual results put First Merchants in focus First Merchants (FRME) has captured investor attention after reporting full year 2025 earnings, with higher net interest income and net income, alongside a quarter that included increased net charge offs. See our latest analysis for First Merchants. That annual report appears to have caught the market’s eye, with the share price at US$42.34 and a 90 day share price return of 17.55% alongside a 5 year total shareholder return of 21%. This suggests...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie Seeks Rinvoq Vitiligo Approval And Extends Immunology Growth Story

AbbVie has submitted regulatory applications to the FDA and EMA for Rinvoq as a potential systemic treatment for non segmental vitiligo. The filings target a condition where there are currently no approved systemic therapies, highlighting a major unmet medical need. The move could broaden the use of one of AbbVie's key immunology assets beyond its existing indications. For investors following AbbVie, NYSE:ABBV, this update comes with the stock recently closing at $223.43. The company has...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Expands Surety Footprint And Flexibility With Acquisition And US$450m Facility

Palomar Holdings (NasdaqGS:PLMR) has completed its acquisition of The Gray Casualty & Surety Company. The company has also secured $450 million in new unsecured financing. The transaction expands Palomar's surety franchise and broadens its geographic footprint. The new financing is intended to support Palomar's operational scale and financial flexibility. Palomar Holdings focuses on specialty insurance, and adding The Gray Casualty & Surety Company gives it a larger presence in the surety...
NYSE:GTLS
NYSE:GTLSMachinery

A Look At Chart Industries (GTLS) Valuation After Recent Mixed Returns And Order Book Momentum

What Chart Industries’ recent performance data tells you Chart Industries (GTLS) has drawn investor attention after recent share performance data highlighted mixed short term moves alongside stronger multi year returns, prompting closer scrutiny of how current fundamentals line up with the price. See our latest analysis for Chart Industries. At a share price of $207.45, Chart Industries has seen only modest recent share price moves. A 1 year total shareholder return of 5.59% and a 3 year...
NYSE:HL
NYSE:HLMetals and Mining

Is Rising Output And Reinvestment Over Dividends Altering The Investment Case For Hecla Mining (HL)?

In late January 2026, Hecla Mining Company reported higher full-year 2025 production of silver, gold and lead, issued 2026 production guidance, and scheduled a call to discuss the acquisition of its Quebec assets. The combination of rising precious metals prices, stronger output and a focus on reinvestment over higher dividends is reshaping how investors assess Hecla’s operations and capital allocation. With recent share gains and fresh 2026 production guidance, we’ll now explore how Hecla’s...
NYSE:JCI
NYSE:JCIBuilding

Johnson Controls (JCI) Is Up 15.4% After Raising 2026 Guidance And Unveiling AI Data Center Cooling

In early February 2026, Johnson Controls International reported first-quarter results with higher revenue and earnings year on year, raised its full-year 2026 earnings guidance, and filed a universal shelf registration covering multiple types of securities. Alongside these financial updates, the company unveiled several advanced YORK chiller technologies and design guides aimed at high-density AI data centers, underscoring its push into mission-critical cooling and digital service...